Back to results
US 2014/0348918 A1Published application
Delayed-release glucocorticoid treatment of asthma
OwnerStephan WITTE, Achim SCHAEFFLERinventors
Life of this patent
Estimating the term…
Abstract
The present invention refers to the treatment of asthma by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.
Claims25
1-49. (canceled)
A method for the treatment of severe nocturnal asthma in a patient in need thereof, which comprises administering to said patient once daily an effective amount of prednisone contained in a delayed release dosage form, wherein said treatment is administered at least for 2 weeks.
Dependencies are inferred from the claim text.